Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Kontrol Technologies Corp N.KNR

Alternate Symbol(s):  KNRLF

Kontrol Technologies Corp. is a provider of energy management, continuous air quality and emission solutions to commercial and industrial consumers. It delivers building intelligence through the Internet of things (IoT), software and cloud technology as well as project integration. Its smart technology is deployed to customers through a cloud-based interface accessible on desktops and mobile... see more

NEO:KNR - Post Discussion

Kontrol Technologies Corp > Questions about KNR for the current shareholders
View:
Post by Capharnaum on Jun 30, 2021 1:03pm

Questions about KNR for the current shareholders

I first looked into KNR when it broke out ($3 shares), but back then the market cap was inflated when compared with sales and production capacity.

Now that the shares have gone back down to earth, I'm taking another look.

I do have a few questions about KNR:

Is Biocloud their only horse? Let's say that Biocloud is a failure (either as a tech, as a product or they can't ramp up sales), is the company worthless or do they have other technology and products that hold value?

In the case of Biocloud... From what I've seen, it looks like a stationnary product that gathers "real-time" information about air quality and that can detect covid. In the event that covid is "controlled", what's the incentive to buy the product, and would the product require a significant discount on its current price? What's the detection range (200 sq feet? 2000 sq feet?) per machine, does it need particular placement based on airflow/distance from a window where UV could kill off the virus in the air (and thus some kind of engineering process) in a building? Is there a minimal viral charge required for covid detection? When it detects covid, can it provide an assessment on the contamination level (one individual vs multiple individuals?) Has there been a study on the value provided with investing in on-site detection devices vs investing in other prevention measures (ie: personal protection equipment)? Concerning potential future airborne viruses, is there any guarantee that machines bought now will be able to effectively detect them?

Thank you for your answers, it will help me determine whether the investment risk into KNR is worth it.
Comment by Jilly17 on Jun 30, 2021 1:15pm
That's quite a lengthy questionnaire! I suggest if you're truly interested do what the rest of us did ...do your own research. Then you cant blame anyone else if it goes down also regardless if it goes up or down you will have a deeper satisfaction in having more knowledge. :)) If it goes up, way up, well kudos to you. ;)
Comment by Trusted91 on Jun 30, 2021 1:21pm
Great questions and the simple answer is Biocloud is an add on to a very strong well positioned core business ie smart buildings technology which will benefit greatly with investment in reducing emissions and energy efficiency. Suggest you look at their Investor presentations etc as they have large property management companies as partners as far as Biocloud it can be adjusted to other viruses ...more  
Comment by Capharnaum on Jun 30, 2021 1:52pm
Thank you, I'll check these out. I did check the presentation and the financials, but there's a lack of details in there. They could put a business case somewhere for shareholders to be able to understand how their model works.
Comment by wilander on Jun 30, 2021 1:54pm
Capharnum, see the link i posted, $2 target.
Comment by Capharnaum on Jun 30, 2021 2:00pm
Thanks, if you have access to the report, would you mind PMing it to me?
Comment by wilander on Jun 30, 2021 2:05pm
I dont. Just the link and then the research note on my other post.
Comment by Capharnaum on Jun 30, 2021 2:29pm
Np, thought you might have access to the analyst's report. What are your thoughts about the relatively flat revenues in the past 8 quarters? Did Covid limit their growth (outside Biocloud) last year? If I invest in KNR and expect a 25-30% growth in top line revenue, is that something reasonable? Think they can get $20M in revenue for 2021? I know they target $100M in their presentation in 5 ...more  
Comment by yearninyank on Jun 30, 2021 1:37pm
Give it a rest with the push polling bullshirt whoever you are. Transperent as sugar underwear.
Comment by Jilly17 on Jun 30, 2021 1:50pm
LOL! Straight and to the point! I'm on the same page as you but my answer was more smoother. ;) What people seem to forget this Biocloud can detect other pathogens as well. I'm quite excited to hear about what HC has determined not just with Covid and all it's variants but also with all the other known dangerous pathogens and pending pandemics. Maybe Biocloud will be even better than ...more  
Comment by yearninyank on Jun 30, 2021 2:04pm
Yes Jilly you are the nice one. :)    Just as soon as I get my BEP dividend I'll spend it here. It ain't much but a symbolic buy at this crazy price will be fun!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities